Capella

Posts Tagged with: Regulus

June 8, 2011

MicroRNAs 103 and 107 regulate insulin sensitivity.

M. Trajkovski et. al, Nature. 2011 Jun 8;474(7353):649-53. doi: 10.1038/nature10112.

Continue reading…

June 6, 2011

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

K. J. Rayner et. al, J Clin Invest. 2011 Jul 1;121(7):2921-31. doi: 10.1172/JCI57275. Epub 2011 Jun 6.

Continue reading…

May 9, 2011

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.

M. P. Boldin et. al, J Exp Med. 2011 Jun 6;208(6):1189-201. Epub 2011 May 9.

Continue reading…

April 25, 2011

MicroRNA-24 regulates vascularity after myocardial infarction

Continue reading…

April 6, 2011

Human glioma growth is controlled by microRNA-10b.

G. Gabriely et. al, Cancer Res. 2011 May 15;71(10):3563-72. Epub 2011 Apr 6.

Continue reading…

February 15, 2011

miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.

J. K. Park et. al, Biochem Biophys Res Commun. 2011 Mar 25;406(4):518-23. Epub 2011 Feb 15.

Continue reading…

February 1, 2011

Comparison of different miR-21 inhibitor chemistries in a cardiac disease model.

T. Thum et. al, J Clin Invest. 2011 Feb 1;121(2):461-2; author reply 462-3. doi: 10.1172/JCI45938. Epub 2011 Feb 1.

Continue reading…

January 1, 2011

What goes up must come down: the emerging role of microRNA in fibrosis.

B. N. Chau et. al, Hepatology. 2011 Jan;53(1):4-6. doi: 10.1002/hep.24071.

Continue reading…

November 22, 2010

Efficient in vivo microRNA targeting of liver metastasis.

C. Huynh et. al, Oncogene. 2011 Mar 24;30(12):1481-8. Epub 2010 Nov 22.

Continue reading…

October 5, 2010

hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.

E. Elyakim et. al, Cancer Res. 2010 Oct 15;70(20):8077-87. Epub 2010 Oct 5.

Continue reading…

This part of our website contains archived information which should not be considered current and may no longer be accurate.